[1]
“Diagnosis and Treatment of MS in Patients Suffering from Various Degrees of the Disease with a Clinical Approach: The Orginal Article”, Journal of Pharmaceutical Negative Results, pp. 1908–1921, Oct. 2022, doi: 10.47750/pnr.2022.13.S01.227.